King & Spalding’s Paris office, which was established in 2009, advises both French and global companies on a wide range of significant legal issues within the transactional, regulatory and disputes areas.
The corporate, finance and investment team represents clients on strategic corporate transactions across the M&A, private equity, capital markets, leveraged finance, tax, energy and real estate sectors. This team also handles sensitive shareholder activism cases, takeovers and takeover defenses.
Our disputes team partners with clients on high-end Commercial and Investor-State International Arbitrations and French-law litigation matters in a host of key business sectors, including environmental and toxic tort law for which we also assist on environmental and safety regulations.
Representing both corporations and their executives in a variety of matters, our Government Matters team focuses primarily on alleged criminal financial fraud offences and other critical regulatory issues.
Our Life Sciences team, part of the firm’s 300+ lawyer global practice, focuses on EU, French and Belgian food and drug law with an emphasis on regulatory issues associated with pharmaceuticals, biologics, medical devices, cosmetics and food.
The office fuses French and international know-how, in an integrated manner, to provide clients with the most effective and efficient solutions for their business and legal priorities, in France and beyond.